Detection of CXADR protein for diagnosis of kidney cancer

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120, C435S007230

Reexamination Certificate

active

07998689

ABSTRACT:
The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.

REFERENCES:
patent: 6210921 (2001-04-01), Finberg et al.
patent: 2003/0224374 (2003-12-01), Dai et al.
patent: 2006/0019256 (2006-01-01), Clarke et al.
patent: 9811221 (1998-03-01), None
patent: 9833819 (1998-08-01), None
patent: 0118542 (2001-03-01), None
patent: 0160860 (2001-08-01), None
patent: 0229072 (2002-04-01), None
patent: 03000012 (2003-01-01), None
patent: 03000928 (2003-01-01), None
patent: 03080640 (2003-10-01), None
Anders, M., et al.,“Disruption of 3D Tissue Integrity Facilitates Adenovirus Infection by Deregulating the Coxsackievirus and Adenovirus Infection,” Feb. 18, 2003, PNAS, vol. 100, No. 4, pp. 1943-1948.
Bruning, A., et al., “Coxsackie and Adenovirus Receptor Promotes Adenocarcinoma Cell Survival and is Expressionally Activated After Transition From Prenoplastic Precursor Lesions to Invasive Adenocarcinomas”, Clinical Cancer Research, Jun. 15, 2005, vol. 11, No. 12, pp. 4316-4320.
Qin, M., et al., “A Novel Role for the Coxsackie Adenovirus Receptor in Mediating Tumor Formation by Lung Cancer Cells”, Cancer Research, Sep. 15, 2004, vol. 64, pp. 6377-6380.
Rauen, K. A., et al., “Expression of the Coxsackie Adenovirus Receptor in Normal Prostate and in Primary and Metatastic Prostate Carcinoma: Potential Relevance to Gene Therapy”, Cancer Research, Jul. 1, 2002, vol. 62, pp. 3812-3818.
U.S. Appl. No. 11/490,374, filed Jul. 21, 2006.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Detection of CXADR protein for diagnosis of kidney cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection of CXADR protein for diagnosis of kidney cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of CXADR protein for diagnosis of kidney cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2738490

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.